Exxonmobil Investment Management Inc. TX lowered its stake in Stryker Corporation (NYSE:SYK) by 12.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,175 shares of the medical technology company’s stock after selling 7,571 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Stryker were worth $7,924,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Stryker by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock worth $3,341,643,000 after purchasing an additional 657,656 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Stryker by 5.2% during the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares during the last quarter. Jensen Investment Management Inc. raised its holdings in shares of Stryker by 11.3% during the third quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock worth $351,141,000 after purchasing an additional 251,685 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of Stryker by 2.8% during the third quarter. Legal & General Group Plc now owns 1,805,572 shares of the medical technology company’s stock worth $256,393,000 after purchasing an additional 49,143 shares during the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of Stryker by 4.8% during the third quarter. Wells Fargo & Company MN now owns 1,742,959 shares of the medical technology company’s stock worth $247,536,000 after purchasing an additional 79,551 shares during the last quarter. 74.90% of the stock is owned by institutional investors and hedge funds.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the sale, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 7.40% of the stock is currently owned by insiders.
Stryker Corporation (SYK) opened at $160.78 on Wednesday. Stryker Corporation has a fifty-two week low of $119.05 and a fifty-two week high of $164.20. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.37 and a quick ratio of 1.61. The firm has a market cap of $60,170.00, a price-to-earnings ratio of 34.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.78.
Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. During the same quarter in the previous year, the company earned $1.39 earnings per share. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. equities research analysts expect that Stryker Corporation will post 6.47 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be issued a $0.47 dividend. This is a boost from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. This represents a $1.88 dividend on an annualized basis and a yield of 1.17%. Stryker’s payout ratio is presently 40.09%.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.